This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Merging index levels with sentiment indicators can enhance conviction and risk controls. This piece provides actionable tips.
21,956 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
MP Materials is at the center of America’s push to secure essential minerals. This guide breaks down whether now is t...
A wave of new positions from hedge funds loading boeing points to a cautious but growing bet that Boeing can rebound ...
Berkshire Hathaway names Greg Abel as CEO, with Buffett signaling strong confidence as the company holds a cash-heavy...
The Senate Banking Committee kicks off markup on the Digital Asset Market Clarity Act as amendments mount and ethics ...
SpaceX is weighing a high-profile IPO that could bring California a much-needed economic boost despite the chatter ar...
SpaceX's S-1 filing exposes Bitcoin exposure and a broader digital-asset playbook, signaling a new price benchmark fo...
The first-quarter earnings season is more than a quarterly ritual. It’s a blueprint for 2026, showing how AI investme...
A smaller biotech is stealing headlines in 2026 by delivering strong trial results and strategic collaborations. This...
Credit to Credo Technology stock rose on a strong earnings beat, but the path ahead hinges on demand for AI infrastru...
Lam Research surged about 21% from its June trough as markets priced in a slower path for rate hikes. This report wei...
Ripple merges Swell with XRPL Apex for its biggest New York conference yet, stitching together enterprise payments an...